Amulet Pharmaceuticals

About:

Amulet Pharmaceuticals discovers and develops novel therapeutics to address known liabilities of current therapies serving unmet markets.

Website: http://www.amuletpharma.com

Top Investors: Wilmington Investor Network, Springboard Capital

Description:

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

Total Funding Amount:

$1.7M

Headquarters Location:

Rockville, Maryland, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)amuletpharma.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2007-03-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai